Patients with peritoneal metastatic pancreatic ductal adenocarcinoma(pmPDAC)with high-level serum carbohydrate antigens(CAs)always suffer extremely dismal prognosis,with a median survival of several months.Herein,we r...
Small cell cancers were initially described in the lungs and later found to occur in a wide range of organs of the body, constituted a disease entity that is characterized by an aggrieve path/course and a huge disease...
BACKGROUND The incidence of anal cancer has been increasing in the United States.Smoking is a well-established risk factor;however,the impact of smoking on disease recurrence and outcome has not been well studied.The ...
Objective:Penile cancer is a rare malignancy in most developed countries,but may represent a significant oncologic challenge in certain African,Asian,and South American regions.Various treatment approaches have been d...
Objective: to study the effect of cetuximab combined with radiotherapy and chemotherapy on head and neck squamous cell carcinoma. Methods: 60 patients with head and neck squamous cell carcinoma who came to the hospita...
Background: Sarcomatoid carcinoma is a rare biphasic malignancy with an epithelial and mesenchymal component. Given its histological particularity, the diagnosis of this tumor still represents a challenge for patholog...
The incidence of esophagogastric junction(EGJ)adenocarcinoma is increasing in developed nations due to the rising prevalence of obesity and gastroesophageal reflux disease.Due to the peculiar location in a histologica...
This work was supported by the Deputy of Research of Zanjan University of Medical Sciences(grant no.A-12-430-42,ethical code:IR.ZUMS.REC.1399.129);MB acknowledges the financial support of the Scientific and Technological Research Council of Turkey for Material Characterization(TUBITAK,217Z069).
Synchronous chemotherapy and radiotherapy,termed chemoradiation therapy,is now an important standard regime for synergistic cancer treatment.For such treatment,nanoparticles can serve as improved carriers of chemother...
Supported by National Natural Science Foundation of China,No.81302129.
BACKGROUND Neoadjuvant chemoradiotherapy(Neo-CRT)is the current standard strategy for treating locally advanced rectal cancer.However,it delays the administration of optimal chemotherapy and increases toxicity.AIM To ...